• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Assessment of Stimulant Use and Cardiovascular Event Risks Among Older Adults
Research Update

Assessment of Stimulant Use and Cardiovascular Event Risks Among Older Adults

May 9, 2023
Talya Shahal, MD.
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Talya Shahal, MD. Dr. Shahal has no financial relationships with companies related to this material.

REVIEW OF: Tadrous M et al, JAMA Netw Open 2021;4(10):e2130795

STUDY TYPE: Cohort study

Stimulant use among older adults has increased in recent years, not only for the treatment of ADHD but also for various off-label indications. We know stimulants are associated with cardiovascular (CV) safety concerns. So how worried should we be when prescribing them to older adults?

In this population-based cohort study, researchers explored the association between a stimulant prescription and the risk of adverse CV events among adults ages 66 years and older in Ontario, Canada, between 2002 and 2016. The researchers used health care databases to compare 6,457 older adults who received a new stimulant prescription to a control group of 24,853 older adults who did not take stimulants. The primary outcome was any CV event, which the investigators defined as an emergency department visit or hospitalization for myocardial infarction, stroke, transient ischemic attack (TIA), or ventricular arrhythmia.

Older adults taking stimulants were found to have a 40% increased risk of CV events at 30 days compared to those who had not received stimulants, but this association was not found at 180 or 365 days after stimulant initiation. A secondary analysis of individual adverse events found that stimulant initiation was associated with a 300% increased risk of ventricular arrhythmia and a 60% increased risk of stroke or TIA at 30 days. The arrhythmia association persisted at 180 days but not 365 days, while the stroke/TIA association did not persist at either time point. Stimulant initiation was also associated with a 240% increase in all-cause mortality in the first 30 days. This risk did not persist at 180 days and even decreased by 30% at 365 days.

The authors note a possible selection bias in which patients who continued stimulant prescriptions over the long term represented a subset of patients at lower CV risk. Other limitations include missing clinical variables such as smoking history, alcohol use, and BMI, which can affect CV risk.

Carlat Take

In older adults, stimulants might not correlate with a significant risk of CV adverse events beyond the first month. However, these findings should be interpreted with caution, particularly as clinicians may discontinue stimulant prescriptions among patients who exhibit early CV symptoms. We should review a patient’s cardiac history, obtain a baseline ECG, and discuss the elevated risk of stroke/TIA and ventricular arrhythmia before starting stimulants. After monitoring our patients during the first weeks of treatment, we can now feel more comfortable continuing stimulant prescriptions for longer durations.

Geriatric Psychiatry Research Update
KEYWORDS stimulant
    Talya Shahal, MD.

    Linking Alzheimer’s and Depression in Patients after Fifty

    More from this author
    www.thecarlatreport.com
    Issue Date: May 11, 2023
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, Substance Disorders in Older Adults, CGPR, April/May/June 2023
    Medication Treatments for Alcohol and Opioid Use Disorder in Older Adults
    Substance Use Disorders in Older Adults: A Growing Concern
    Managing Substance Use in Older Adults
    Screening Tools, Assessment, and Brief Interventions for Substance Use Disorders in Older Adults
    Accelerated Aging
    Assessment of Stimulant Use and Cardiovascular Event Risks Among Older Adults
    Does Coffee Consumption Increase Risk of Dementia and Stroke?
    CME Post-Test, Substance Use Disorders in Older Adults, CGPR, April/May/June 2023
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2603816031.jpg
      General Psychiatry

      A Scam for Every Woman, Child, and Man: Part 2

      1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.